Concepedia

Timothy Isaac Johnson

TI

11

Publications

1.4K

Citations

11

H-Index

2015

Active since

Affiliations

University of Cambridge(Current)

Medical Research Council

Cancer Research UK

Cancer Research UK Scotland Institute

Cambridge University Hospitals NHS Foundation Trust

Timothy Isaac Johnson is an author at University of Cambridge specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2015–2022

11

Publications

11

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Marco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson et al. · Nature · 2016 · 562 citations · Full text

, , +6

Fumarate induces redox-dependent senescence by modifying glutathione metabolism

Liang Zheng, Simone Cardaci, Livnat Jerby et al. · Nature Communications · 2015 · 287 citations · Full text

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Daniele Biasci, Martin Smoragiewicz, Claire M. Connell et al. · Proceedings of the National Academy of Sciences · 2020 · 241 citations · Full text

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine <i>In Vitro</i> and <i>In Vivo</i> to Induce Pancreatic Ductal Adenocarcinoma Regression

Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson et al. · Molecular Cancer Therapeutics · 2018 · 106 citations · Full text

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models

Charles R. Dunlop, Yann Wallez, Timothy Isaac Johnson et al. · British Journal of Cancer · 2020 · 56 citations · Full text

Rows per page

1–5 of 11